Eden Research inks Colombia flower deal

Eden Research PLC (AIM:EDEN, OTCQB:EDNSF) has chosen Anasac Colombia as the exclusive distributor for its biopesticide, Mevalone, in the South American country.

This selection comes ahead of a pending regulatory application that, if approved, would allow the use of Mevalone to treat ornamental plants, including freshly cut flowers, to prevent and treat Botrytis cinerea infection.

"We expect this initial target application to be the first of many to come in Colombia as we seek to expand the Mevalone label to other crops and disease targets," said Eden chief executive Sean Smith in a statement.

"Our continued territorial push across mature and emerging markets underlines our commitment to serving the growing global demand for sustainable disease and pest control in horticulture," he added.

Botrytis cinerea is a common fungal infection in both growing and harvested flowers, affecting their lifespan and aesthetic quality. Given Colombia's warm and humid climate, the use of fungicides such Mevalone is commonplace, particularly for flowers destined for export.

Read more at proactiveinvestors.com

Publication date:

Receive the daily newsletter in your email for free | Click here

Other news in this sector:

Sign up for our daily Newsletter and stay up to date with all the latest news!

Subscribe I am already a subscriber

You are using software which is blocking our advertisements (adblocker).

As we provide the news for free, we are relying on revenues from our banners. So please disable your adblocker and reload the page to continue using this site.

Click here for a guide on disabling your adblocker.